Universal Health Realty Income Trust
7 nominees · 4 ballot items.
Shareholders will vote to elect two Class I Trustees, cast an advisory (nonbinding) vote to approve named executive officer compensation (“say-on-pay”), ratify KPMG LLP as the Trust’s independent registered public accounting firm for the fiscal year ending December 31, 2026, and transact any other business properly brought before the meeting.
Follow how the vote landed and what changed on Universal Health Realty Income Trust’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot4
- 1
Election of Two Class I Trustees
ManagementBoard: FORElection of two Class I Trustees (Alan B. Miller and Robert F. McCadden) to serve three-year terms expiring in 2029.
- 2
Advisory Vote on Named Executive Officer Compensation
ManagementBoard: FORNonbinding advisory ("say-on-pay") vote to approve the compensation paid to the Trust’s named executive officers as disclosed in the proxy statement.
More detail
This management proposal requests a non-binding, advisory approval of the Trust’s named executive officer (NEO) compensation as disclosed in the proxy materials, effectively asking shareholders to endorse the overall compensation philosophy and disclosed pay outcomes rather than any single element of pay. Management is seeking approval to demonstrate shareholder support for its compensation practices, which rely heavily on stock-based long-term incentives and an advisory arrangement with UHS that provides executive personnel and services; the proxy highlights enhanced disclosures about the Advisor fee, allocation of Advisor-paid compensation, and UHT stock awards to improve transparency. The Trust frames this vote as an annual opportunity for shareholders to express their views and notes that the Compensation Committee will consider the voting outcome when setting future compensation, though the vote remains non-binding. Contextually, the Trust has historically structured executive pay largely through restricted stock awards and an advisory fee to UHS; the proxy discloses how advisory fees and equity awards compare to peer groups and provides a pay-versus-performance analysis. Management emphasizes that enhanced disclosures have correlated with strong historical shareholder support (95% in 2024, 94% in 2023, and 93% in 2022) to justify continued reliance on the current program. The board’s recommendation to vote FOR is grounded in its view that the compensation program aligns executives’ interests with long-term shareholder value, that advisory and equity arrangements are reasonable versus peers, and that recent grant practices (fixed-dollar equity awards tied to peer benchmarking and TSR-based performance metrics) provide appropriate incentives. The proposal is procedurally an ordinary majority vote and is informational to investors and governance stakeholders; because it is advisory, a negative result would not automatically change pay but would prompt the Compensation Committee to reassess policies and disclosures. Analysts should weigh the Trust’s dependence on an external advisor, the concentration of revenue with UHS-related tenants, and the relatively simple compensation structure when evaluating whether a ‘‘FOR’’ recommendation signals substantive alignment or primarily reflects customary practice at advisor-managed REITs.
- 3
Ratification of the Selection of Independent Registered Public Accountants
ManagementBoard: FORRatify the Audit Committee’s selection of KPMG LLP as the Trust’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
- 4
Transaction of Other Business
ManagementTransact such other business as may properly come before the meeting or any adjournment thereof (discretionary matters), with proxies granted discretionary authority to vote on such matters.
Nominees on the ballot7
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 10.4% | 1,444,825 | $58M |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 6.9% | 957,786 | $39M |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 4.3% | 595,253 | $24M |
| 4 | STATE STREET CORP | 4.0% | 559,260 | $23M |
| 5 | BlackRock, Inc. | 3.3% | 451,970 | $18M |
| 6 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 2.5% | 340,130 | $14M |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 307,014 | $12M |
| 8 | RENAISSANCE TECHNOLOGIES LLC | 1.6% | 220,110 | $9M |
| 9 | BlackRock, Inc. | 1.5% | 211,465 | $9M |
| 10 | DIMENSIONAL FUND ADVISORS LP | 1.3% | 177,493 | $7M |
Other Real Estate sector meetings6
Upcoming shareholder meetings at Universal Health Realty Income Trust’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Universal Health Realty Income Trust 2026 annual meeting?
- Universal Health Realty Income Trust (UHT) holds its 2026 annual shareholder meeting on Wednesday, June 10, 2026.
- What is the record date for the Universal Health Realty Income Trust 2026 meeting?
- The record date for the Universal Health Realty Income Trust 2026 meeting is Monday, April 13, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Universal Health Realty Income Trust's 2026 meeting?
- The board is presenting 7 director nominees at the Universal Health Realty Income Trust 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Universal Health Realty Income Trust 2026 meeting?
- Shareholders will vote on 4 proposals at the Universal Health Realty Income Trust 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.